RxDoctor Payments Data

Matthew Phillips, MD

Orthopaedic Surgery · Buffalo, NYNPI 1629042239

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 67.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $27,206 and has fallen 95.4% since, to $1,246 in 2025.

$82,339in general payments, 2019–2025

Across 112 payments — averaging $735.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$56K
  • Stryker$26K
  • Zimmer Biomet$350
  • Johnson & Johnson$185
  • Medical Device Business Services, Inc.$115
  • Baxter Healthcare$86
  • plus $137 from 5 others
$19,658in research payments, 2019–2025

Across 12 payments — averaging $1638.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$20K

What the payments were for

  • Consulting fees$21,80026%
  • Speaking & faculty fees$46,62557%
  • Travel & lodging$8,70611%
  • Food & beverage$5,2086%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,339 in reported general payments places this provider in the 85th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$108,191
Medicare patients
233
Services billed
621

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Buffalo

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →